DK100686D0 - Vanddispergerbare og vandoploeselige midler til parenteral indgift - Google Patents

Vanddispergerbare og vandoploeselige midler til parenteral indgift

Info

Publication number
DK100686D0
DK100686D0 DK100686A DK100686A DK100686D0 DK 100686 D0 DK100686 D0 DK 100686D0 DK 100686 A DK100686 A DK 100686A DK 100686 A DK100686 A DK 100686A DK 100686 D0 DK100686 D0 DK 100686D0
Authority
DK
Denmark
Prior art keywords
water
parenteral administration
water soluble
dispersible
water dispersible
Prior art date
Application number
DK100686A
Other languages
English (en)
Other versions
DK100686A (da
Inventor
Susan Mancini Cady
Richard Fishbein
Ulf Schroeder
Haakan Eriksson
Brenda Lee Probasco
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8501094A external-priority patent/SE8501094D0/xx
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK100686D0 publication Critical patent/DK100686D0/da
Publication of DK100686A publication Critical patent/DK100686A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pens And Brushes (AREA)
  • Organic Insulating Materials (AREA)
DK100686A 1985-03-06 1986-03-05 Vanddispergerbare og vandoploeselige midler til parenteral indgift DK100686A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8501094A SE8501094D0 (sv) 1985-03-06 1985-03-06 Biologiskt aktiv komposition och forfarande for framstellning derav
US71741785A 1985-03-29 1985-03-29
US83015886A 1986-02-20 1986-02-20

Publications (2)

Publication Number Publication Date
DK100686D0 true DK100686D0 (da) 1986-03-05
DK100686A DK100686A (da) 1986-09-07

Family

ID=27355321

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100686A DK100686A (da) 1985-03-06 1986-03-05 Vanddispergerbare og vandoploeselige midler til parenteral indgift

Country Status (11)

Country Link
EP (1) EP0193917A3 (da)
KR (1) KR890004687B1 (da)
AU (1) AU591478B2 (da)
DK (1) DK100686A (da)
ES (1) ES8704347A1 (da)
FI (1) FI860923A (da)
GR (1) GR860610B (da)
IL (1) IL78031A0 (da)
NO (1) NO860832L (da)
NZ (1) NZ215366A (da)
PT (1) PT82150B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
US4863736A (en) 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
EP0303746B2 (en) * 1987-08-21 1998-12-02 Mallinckrodt Group Inc. Stabilization of growth promoting hormones
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
FR2637501A1 (fr) * 1988-10-07 1990-04-13 Inst Develop Valorisa Biotec Composition stabilisee a base de facteurs de croissance de la famille fgf et de dextrane sulfate, et ses applications
CA2046324A1 (en) * 1989-01-26 1990-07-27 Wen-Ghih Tsang Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
NZ237084A (en) * 1990-02-12 1993-10-26 Lucky Ltd Composition for the prolonged release of somatotropin comprising the somatotropin, a tocopherol component, and an assistant delaying agent
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
NZ234439A (en) * 1990-07-10 1997-08-22 Pharmacia & Upjohn Ab Use of igf-1 to reduce fetal growth retardation in non human mammals
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
GB9102107D0 (en) * 1991-01-31 1991-03-13 Erba Carlo Spa Stabilisation of fibroblast growth factor using a polysaccharide
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
CZ296649B6 (cs) * 1993-02-23 2006-05-17 Genentech, Inc. Zpusob výroby stabilizovaného polypeptidového prostredku zahrnující stabilizování polypeptidu protidenaturaci organickými rozpoustedly, jeho príprava a prostredek pro regulované uvolnování polypeptidu
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
US7052721B2 (en) 2000-04-05 2006-05-30 Hafsteinn Helgason Recovery of compounds using a natural adsorbent
EP2700431A1 (en) 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE396693B (sv) * 1970-02-16 1977-10-03 Paulsen Fredrik Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan
GB1345513A (en) * 1973-01-12 1974-01-30 Vosper Thornycroft Ltd Gas cushion vehicle
FR2265043A1 (en) * 1974-03-18 1975-10-17 Dietrich & Cie De Roasting oven with several spits - has single motor turning all spits together through common crank plate
DE2512943A1 (de) * 1974-04-02 1975-10-16 Sandoz Ag Verfahren zur herstellung protrahiert wirksamer injektionspraeparate
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung

Also Published As

Publication number Publication date
NZ215366A (en) 1988-07-28
KR860006985A (ko) 1986-10-06
EP0193917A3 (en) 1987-09-23
AU591478B2 (en) 1989-12-07
KR890004687B1 (ko) 1989-11-25
FI860923A (fi) 1986-09-07
IL78031A0 (en) 1986-07-31
ES8704347A1 (es) 1987-04-01
NO860832L (no) 1986-09-08
DK100686A (da) 1986-09-07
ES552690A0 (es) 1987-04-01
EP0193917A2 (en) 1986-09-10
GR860610B (en) 1986-06-30
AU5430686A (en) 1986-10-16
PT82150A (en) 1986-04-01
PT82150B (pt) 1988-02-17
FI860923A0 (fi) 1986-03-05

Similar Documents

Publication Publication Date Title
DK100686D0 (da) Vanddispergerbare og vandoploeselige midler til parenteral indgift
DK491186A (da) Pyridonderivater og fremgangsmaade til fremstilling deraf
NO860190L (no) Peptid-derivater og fremgangsmaate for fremstilling derav.
DK597788D0 (da) Indgiftssystem og fremstilling deraf
DK301886D0 (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK291186A (da) Antianafylaktiske og antibronchospastiske n-benzhydryldiazacykloalkylalkananilider
DK51286A (da) Desoxyadenosinphosphatforbindelser og fremgangsmaade til fremstilling afdisse
DK35687D0 (da) Isoquinolinderivater og fremgangsmaade til fremstilling deraf
NO166313C (no) Fremgangsmaate og innretning for kontinuerlig fremstillingav surimimasse.
DK335986A (da) Poly-4-aminopropyl-2-carboxamidoderivat og fremgangsmaade til fremstilling deraf
KR870005448U (ko) 관 접속구
DK103986A (da) Quinoloncarboxylsyre-derivat og fremgangsmaade til fremstilling heraf
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK161086D0 (da) Nitrofuranderivater samt fremgangsmaade til fremstilling og anvendelse deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK413187A (da) Semicarbazoner og thiosemicarbazoner
NO169679C (no) Fremgangsmaate og system for lokalisering og orientering
DK401385D0 (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
NO863603D0 (no) Fremgangsmaate og anordning for fastgjoering under vann.
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK50686A (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK443787D0 (da) Hydrazonderivater og fremgangsmaade til fremstilling deraf
KR870012491U (ko) 파이프 연결구
KR880004793U (ko) 관 연결구

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment